NASDAQ RESUMED AT 10:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:50 AM
NASDAQ RESUMED AT 10:49 AM
U.S. STOCKS ON THE MOVE-Amneal Pharma, Ardelyx, Snap
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:44 AM
NASDAQ RESUMED AT 10:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:38 AM
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International
CalciMedica tumbles as safety concerns halt trial of kidney injury drug
NASDAQ RESUMED AT 07:40 AM
Brief: CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
CalciMedica reports Q3 net loss of $7.8 mln
CalciMedica Inc reports results for the quarter ended June 30 - Earnings Summary
CalciMedica Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Calcimedica Announces Publication In The American Journal Of Nephrology Discussing Design
CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary